LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
US Stock MarketDetailed Quotes
TGTX TG Therapeutics
- 30.090
- +1.560+5.47%
Close Feb 28 16:00 ET
- 30.110
- +0.020+0.07%
Post 19:58 ET
4.68BMarket Cap-300.90P/E (TTM)
30.370High28.170Low2.42MVolume28.300Open28.530Pre Close71.47MTurnover1.67%Turnover Ratio334.33P/E (Static)155.67MShares36.84052wk High24.38P/B4.36BFloat Cap12.93052wk Low--Dividend TTM144.91MShs Float149414.006Historical High--Div YieldTTM7.71%Amplitude0.956Historical Low29.530Avg Price1Lot Size
TG Therapeutics News
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer WEISS MICHAEL S
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Power Sean A
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Power Sean A
TG Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Darwin Global Management, Ltd.(0%),Dr. Abhishek Trehan(0%), etc.
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lonial Sagar
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Charney Laurence N
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Echelard Yann
TG Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(14.2%)
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lonial Sagar
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director HUME DANIEL
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hoberman Kenneth
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Echelard Yann
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Charney Laurence N
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lonial Sagar
TG Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Charney Laurence N
TG Therapeutics | 5: Annual statement of changes in beneficial ownership of securities-Officer Power Sean A
TG Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Darwin Global Management, Ltd.(2.7%),Dr. Abhishek Trehan(2.7%), etc.
TG Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(9.03%)
TG Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(7.1%)
TG Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(5.45%)
Trending Stocks
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve
Moo Earnings
Feb 2 12:39
AMZN earnings preview: Grab rewards by guessing the opening price!